Researchers at the Winship Cancer Institute of Emory University have been studying ways to assess drug treatment response in glioblastoma patients, and their efforts recently got a boost with a $4 million National Cancer Institute grant. The team has been using magnetic resonance spectroscopy to assess changes in tumor metabolism. "It lets us see something we otherwise couldn't see, something that can help us make best decisions for our patients. Glioblastoma is just an awful disease, and anything that can lighten the burden is tremendously important," said neurosurgeon Dr. Jeffrey Olson.

Related Summaries